nejm retatrutide phase 2 2023 percent weight loss 48 weeks Retatrutide (not yet approved in US but people using anyway) promises even potentially greater weight loss amongst the GLP1 drugs. https://www.nejm .org/doi/full/10.1056/NEJMoa2301972 ESC 2024: Retatrutide improves lipid

My friend reached her 25 lb goal in 3 months and referred me here

GLP-1 Therapy Part 1: Setting Realistic Weight Loss Expectations I recently had the pleasure of speaking at the Colorado Academy of Nutrition and Dietetics Annual Conference on the topic of nutrition strategies for effective GLP-1 use in obesity treatment

Individual compound safety profiles exist

Care model and oversight: Hims is designed around asynchronous intake and messaging

Known as the closest at-home alternative to a professional treatment, it combines four modes including EMS (electric muscle stimulation)for firming, and a "Booster" mode to help skincare penetrate deeper

Get In Touch With Us GLP-1 Lawsuit MDL Update (JuneNovember 2025) From June through November 2025, the GLP-1 receptor agonist multidistrict litigation (MDL 3094) expanded rapidly, with the number of pending lawsuits increasing from approximately 1,882 cases in early June to more than 2,900 cases by early November , according to reports from the Judicial Panel on Multidistrict Litigation (JPML)